自体动静脉内瘘早期成熟不良研究进展  

Research progress on early poor maturation of autologous arteriovenous fistulas

作　　者：谢战场 余康敏[1] Xie Zhanchang;Yu Kangmin(Department of Vascular Surgery,the First Affiliated Hospital of Anhui Medical University,Hefei 230022,Anhui,China)

机构地区：[1]安徽医科大学第一附属医院血管外科,安徽合肥230022

出　　处：《血管与腔内血管外科杂志》2025年第2期212-216,共5页Journal of Vascular and Endovascular Surgery

摘　　要：自体动静脉内瘘(AVF)具有安全、有效、使用周期长、并发症发生率低的优势,成为血液透析患者的首选血管通路。然而,由于各种原因导致的AVF成熟不良限制了其临床应用,但具体病因机制尚不明确。因此,多种器械辅助、药物等干预方式可促进AVF的形成和成熟,具体的选择因患者个体化差异而不同。本综述对AVF成熟不良的病因机制进行探讨,并对现有的促成熟方法进行归纳总结。Autogenous arteriovenous fistula(AVF)has the advantages of safety,effectiveness,long service life,and low incidence of complications,making it the preferred vascular pathway for hemodialysis patients.However,the poor maturation of AVF due to various reasons has limited its clinical application,but the specific pathogenesis is still unclear.Therefore,various intervention methods such as instrument assistance and medication can promote the formation and maturation of AVF,and the specific choice varies depending on individual patient differences.This review explores the pathogenic mechanisms of AVF dysmaturation and summarizes existing methods for promoting maturation.

关 键 词：动静脉内瘘 成熟不良 促成熟 

分 类 号：R543[医药卫生—心血管疾病]